A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic SteatohepatitisDepartment of Medicine | College of Medicine – Jacksonville

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis

Study Description

The purpose of this study is to find out if OCA may be safe and effective in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis.

Subjects will be randomized to 1 of 2 study drug doses or placebo.

Open Enrollment

Contact Name: Kelly Jackman
Contact Phone: (904) 633-0070
Contact Email: Kelly.Jackman@jax.ufl.edu

Investigators

Principal Investigator
Maged P. Ghali, M.D.
Medicine

Principal Investigator
James S. Scolapio, M.D.
Medicine